For instance, a marked correlation between RNASET2 expression and overall survival (OS) in epithelial ovarian cancer patients has been reported in two independent datasets, whereby patients whose tumors displayed low RNASET2 expression showed a significantly shorter OS compared to high-RNASET2 expression patients [50]. This evidence concerns the gene RNASET2 and ovarian carcinoma.